RESUMEN
INTRODUCTION: Social anxiety disorder is believed to be a stress-induced disease. Although it can be inferred from the symptoms during attacks that there exists some abnormality of autonomic nervous system in any of the stress systems in social anxiety disorder, little evidence has been reported. This study focused on comparing the reactivity of 2 stress systems, the autonomic nervous system (ANS) and the hypothalamic-pituitary-adrenal (HPA) axis in patients with social anxiety disorder. METHODS: 32 patients with the generalized type of social anxiety disorder were compared with 80 age- and gender-matched controls. We collected saliva samples from patients and controls before and after electrical stimulation to measure the concentrations of salivary alpha-amylase (sAA) and salivary cortisol. Profile of Mood State (POMS) and State-Trait Anxiety Inventory (STAI) scores and Heart Rate Variability (HRV) were also determined following stimulation. RESULTS: SAA in patients displayed a significantly higher level at baseline and a significantly larger response to electrical stimulation as compared to controls, whereas no group differences were seen in any HRV. Neither within-subject nor group differences were seen in salivary cortisol levels. CONCLUSIONS: These results suggest that SAD patients displayed enhanced ANS (but not HPA axis) activity vs. healthy controls.
Asunto(s)
Trastornos de Ansiedad/metabolismo , Hidrocortisona/metabolismo , alfa-Amilasas/metabolismo , Adulto , Trastornos de Ansiedad/enzimología , Trastornos de Ansiedad/fisiopatología , Sistema Nervioso Autónomo/fisiopatología , Estudios de Casos y Controles , Estimulación Eléctrica , Femenino , Frecuencia Cardíaca/fisiología , Humanos , Sistema Hipotálamo-Hipofisario/fisiopatología , Masculino , Nervio Mediano/fisiología , Sistema Hipófiso-Suprarrenal/fisiopatología , Saliva/metabolismoRESUMEN
OBJECTIVE: Fahr disease (FD) is a rare neurological and psychiatric disorder. The disease is classified by intracranial calcification of the basal ganglia with the globus pallidus region being particularly affected. We examined a young woman with visual hallucinations, delusions of persecution and a history of performing arson with possible third-generation FD. METHOD: Case report of third-generation FD. RESULTS: A 23-year-old woman was arrested for two arsons: i) The patient exhibited progressive psychotic symptoms, including visual hallucinations, delusion of injury, irritability, lability of mood, mental retardation and visual disorders and ii) Computed tomography (CT) imaging demonstrated bilateral calcifications of the basal ganglia (globus pallidus) in the patient, her mother and her grandmother. CONCLUSION: We found a family with a three-generation history of FD who exhibited calcification in the brain and mental retardation. Compared to her mother, the patient described here displayed anticipation of disease onset.
Asunto(s)
Enfermedades de los Ganglios Basales/epidemiología , Enfermedades de los Ganglios Basales/genética , Calcinosis/diagnóstico , Calcinosis/genética , Deluciones/epidemiología , Deluciones/genética , Piromanía/epidemiología , Trastornos Psicóticos/epidemiología , Trastornos Psicóticos/genética , Adulto , Edad de Inicio , Anticipación Genética/genética , Enfermedades de los Ganglios Basales/diagnóstico , Calcinosis/epidemiología , Comorbilidad , Femenino , Globo Pálido/patología , Humanos , Discapacidad Intelectual/diagnóstico , Discapacidad Intelectual/epidemiología , Discapacidad Intelectual/genética , Aplicación de la Ley/métodos , Linaje , Prisioneros/estadística & datos numéricos , Trastornos Psicóticos/diagnóstico , Síndrome , Tomografía Computarizada por Rayos X/estadística & datos numéricosRESUMEN
Effect of YM175, a new bisphosphonate, on vitamin D metabolism was studied in rats. When animals were treated with the compound, serum 1,25-dihydroxyvitamin D increased in a dose dependent manner. The effect was also detected in thyroparathyroidectomized animals. The effect appears to be due to the stimulation of renal production of the hormone, since renal 1-hydroxylase was also elevated in these animals. However, when kidneys were incubated with YM175 and then renal 1-hydroxylase activity was examined, the enzyme activity was not different from that of non-treated control kidney. We conclude therefore that YM175 indirectly stimulates renal 25-hydroxyvitamin D-1-hydroxylase by increasing circulating parathyroid hormone via an unknown mechanism independent of parathyroid hormone. This is the first direct demonstration of increase in the renal production of 1,25-dihydroxyvitamin D resulting from bisphosphonate treatment.